Summary

Global Contrast Media Market 2023-2027
The contrast media market is forecasted to grow by USD 946.31 mn during 2022-2027, accelerating at a CAGR of 3.36% during the forecast period. The report on the contrast media market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing geriatric population and chronic and infectious diseases, the rise in healthcare spending, and the approval of new contrast media.
Technavio's contrast media market is segmented as below:
By Modality
• X-ray/CT
• MRI
• Ultrasound
By Application
• Neurological disorders
• Cardiovascular disorders
• Cancer
• Gastrointestinal disorders
• Others
By Geographical Landscape
• North America
• Europe
• APAC
• South America
• Middle East and Africa
This study identifies the launch of new contrast media as one of the prime reasons driving the contrast media market growth during the next few years. Also, increasing R and D focus on contrast media injectors and increasing production of contrast media will lead to sizable demand in the market.
The report on the contrast media market covers the following areas:
• Contrast media market sizing
• Contrast media market forecast
• Contrast media market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading contrast media market vendors that include Bayer AG, Beijing Beilu Pharmaceutical Co. Ltd., Blue Jet Healthcare Ltd., Bracco Spa, Covis Pharma GmbH, GE Healthcare Technologies Inc., Guerbet, iMAX Diagnostic Imaging Ltd., Interpharma Praha as, JB Chemicals and Pharmaceuticals Ltd., Jodas Expoim Pvt. Ltd., Lantheus Holdings Inc., Livealth Biopharma Pvt. Ltd., M.Biotech Ltd., Nano Therapeutics Pvt. Ltd., Novalek Pharmaceuticals Pvt Ltd., SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Taejoon Pharm Co. Ltd., and Unijules Life Sciences Ltd.. Also, the contrast media market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/contrast-media-market-analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Modality
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global contrast media market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global contrast media market 2017 - 2021 ($ million)
o 4.2 Modality Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Modality Segment 2017 - 2021 ($ million)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Modality
o 6.1 Market segments
o Exhibit 30: Chart on Modality - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Modality - Market share 2022-2027 (%)
o 6.2 Comparison by Modality
o Exhibit 32: Chart on Comparison by Modality
o Exhibit 33: Data Table on Comparison by Modality
o 6.3 X-ray/CT - Market size and forecast 2022-2027
o Exhibit 34: Chart on X-ray/CT - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on X-ray/CT - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on X-ray/CT - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on X-ray/CT - Year-over-year growth 2022-2027 (%)
o 6.4 MRI - Market size and forecast 2022-2027
o Exhibit 38: Chart on MRI - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on MRI - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on MRI - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on MRI - Year-over-year growth 2022-2027 (%)
o 6.5 Ultrasound - Market size and forecast 2022-2027
o Exhibit 42: Chart on Ultrasound - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Ultrasound - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Ultrasound - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Ultrasound - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Modality
o Exhibit 46: Market opportunity by Modality ($ million)
o Exhibit 47: Data Table on Market opportunity by Modality ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 48: Chart on Application - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 50: Chart on Comparison by Application
o Exhibit 51: Data Table on Comparison by Application
o 7.3 Neurological disorders - Market size and forecast 2022-2027
o Exhibit 52: Chart on Neurological disorders - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Neurological disorders - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Neurological disorders - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Neurological disorders - Year-over-year growth 2022-2027 (%)
o 7.4 Cardiovascular disorders - Market size and forecast 2022-2027
o Exhibit 56: Chart on Cardiovascular disorders - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Cardiovascular disorders - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Cardiovascular disorders - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Cardiovascular disorders - Year-over-year growth 2022-2027 (%)
o 7.5 Cancer - Market size and forecast 2022-2027
o Exhibit 60: Chart on Cancer - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Cancer - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Cancer - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
o 7.6 Gastrointestinal disorders - Market size and forecast 2022-2027
o Exhibit 64: Chart on Gastrointestinal disorders - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Gastrointestinal disorders - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Gastrointestinal disorders - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Gastrointestinal disorders - Year-over-year growth 2022-2027 (%)
o 7.7 Others - Market size and forecast 2022-2027
o Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Application
o Exhibit 72: Market opportunity by Application ($ million)
o Exhibit 73: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 77: Chart on Geographic comparison
o Exhibit 78: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 APAC - Market size and forecast 2022-2027
o Exhibit 87: Chart on APAC - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on APAC - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on APAC - Year-over-year growth 2022-2027 (%)
o 9.6 South America - Market size and forecast 2022-2027
o Exhibit 91: Chart on South America - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on South America - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on South America - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on South America - Year-over-year growth 2022-2027 (%)
o 9.7 Middle East and Africa - Market size and forecast 2022-2027
o Exhibit 95: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
o 9.8 US - Market size and forecast 2022-2027
o Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.9 Japan - Market size and forecast 2022-2027
o Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.10 Germany - Market size and forecast 2022-2027
o Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 UK - Market size and forecast 2022-2027
o Exhibit 115: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 116: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 117: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 118: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.13 Market opportunity By Geographical Landscape
o Exhibit 119: Market opportunity By Geographical Landscape ($ million)
o Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 121: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 123: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 124: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 125: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 126: Matrix on vendor position and classification
o 12.3 Bayer AG
o Exhibit 127: Bayer AG - Overview
o Exhibit 128: Bayer AG - Business segments
o Exhibit 129: Bayer AG - Key news
o Exhibit 130: Bayer AG - Key offerings
o Exhibit 131: Bayer AG - Segment focus
o 12.4 Beijing Beilu Pharmaceutical Co. Ltd.
o Exhibit 132: Beijing Beilu Pharmaceutical Co. Ltd. - Overview
o Exhibit 133: Beijing Beilu Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 134: Beijing Beilu Pharmaceutical Co. Ltd. - Key offerings
o 12.5 Bracco Spa
o Exhibit 135: Bracco Spa - Overview
o Exhibit 136: Bracco Spa - Product / Service
o Exhibit 137: Bracco Spa - Key offerings
o 12.6 Covis Pharma GmbH
o Exhibit 138: Covis Pharma GmbH - Overview
o Exhibit 139: Covis Pharma GmbH - Product / Service
o Exhibit 140: Covis Pharma GmbH - Key offerings
o 12.7 GE Healthcare Technologies Inc.
o Exhibit 141: GE Healthcare Technologies Inc. - Overview
o Exhibit 142: GE Healthcare Technologies Inc. - Business segments
o Exhibit 143: GE Healthcare Technologies Inc. - Key offerings
o Exhibit 144: GE Healthcare Technologies Inc. - Segment focus
o 12.8 Guerbet
o Exhibit 145: Guerbet - Overview
o Exhibit 146: Guerbet - Product / Service
o Exhibit 147: Guerbet - Key offerings
o 12.9 iMAX Diagnostic Imaging Ltd.
o Exhibit 148: iMAX Diagnostic Imaging Ltd. - Overview
o Exhibit 149: iMAX Diagnostic Imaging Ltd. - Product / Service
o Exhibit 150: iMAX Diagnostic Imaging Ltd. - Key offerings
o 12.10 Interpharma Praha as
o Exhibit 151: Interpharma Praha as - Overview
o Exhibit 152: Interpharma Praha as - Product / Service
o Exhibit 153: Interpharma Praha as - Key offerings
o 12.11 Jodas Expoim Pvt. Ltd.
o Exhibit 154: Jodas Expoim Pvt. Ltd. - Overview
o Exhibit 155: Jodas Expoim Pvt. Ltd. - Product / Service
o Exhibit 156: Jodas Expoim Pvt. Ltd. - Key offerings
o 12.12 Lantheus Holdings Inc.
o Exhibit 157: Lantheus Holdings Inc. - Overview
o Exhibit 158: Lantheus Holdings Inc. - Business segments
o Exhibit 159: Lantheus Holdings Inc. - Key offerings
o Exhibit 160: Lantheus Holdings Inc. - Segment focus
o 12.13 Livealth Biopharma Pvt. Ltd.
o Exhibit 161: Livealth Biopharma Pvt. Ltd. - Overview
o Exhibit 162: Livealth Biopharma Pvt. Ltd. - Product / Service
o Exhibit 163: Livealth Biopharma Pvt. Ltd. - Key offerings
o 12.14 M.Biotech Ltd.
o Exhibit 164: M.Biotech Ltd. - Overview
o Exhibit 165: M.Biotech Ltd. - Product / Service
o Exhibit 166: M.Biotech Ltd. - Key offerings
o 12.15 Nano Therapeutics Pvt. Ltd.
o Exhibit 167: Nano Therapeutics Pvt. Ltd. - Overview
o Exhibit 168: Nano Therapeutics Pvt. Ltd. - Product / Service
o Exhibit 169: Nano Therapeutics Pvt. Ltd. - Key offerings
o 12.16 Spago Nanomedical AB
o Exhibit 170: Spago Nanomedical AB - Overview
o Exhibit 171: Spago Nanomedical AB - Product / Service
o Exhibit 172: Spago Nanomedical AB - Key offerings
o 12.17 Taejoon Pharm Co. Ltd.
o Exhibit 173: Taejoon Pharm Co. Ltd. - Overview
o Exhibit 174: Taejoon Pharm Co. Ltd. - Product / Service
o Exhibit 175: Taejoon Pharm Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 176: Inclusions checklist
o Exhibit 177: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 178: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 179: Research methodology
o Exhibit 180: Validation techniques employed for market sizing
o Exhibit 181: Information sources
o 13.5 List of abbreviations
o Exhibit 182: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Modality
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global contrast media market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Modality Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Modality - Market share 2022-2027 (%)
Exhibits31: Data Table on Modality - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Modality
Exhibits33: Data Table on Comparison by Modality
Exhibits34: Chart on X-ray/CT - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on X-ray/CT - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on X-ray/CT - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on X-ray/CT - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on MRI - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on MRI - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on MRI - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on MRI - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Ultrasound - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Ultrasound - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Ultrasound - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Ultrasound - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Modality ($ million)
Exhibits47: Data Table on Market opportunity by Modality ($ million)
Exhibits48: Chart on Application - Market share 2022-2027 (%)
Exhibits49: Data Table on Application - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Application
Exhibits51: Data Table on Comparison by Application
Exhibits52: Chart on Neurological disorders - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Neurological disorders - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Neurological disorders - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Neurological disorders - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Cardiovascular disorders - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Cardiovascular disorders - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Cardiovascular disorders - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Cardiovascular disorders - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Cancer - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Cancer - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Cancer - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Gastrointestinal disorders - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Gastrointestinal disorders - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Gastrointestinal disorders - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Gastrointestinal disorders - Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits70: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits72: Market opportunity by Application ($ million)
Exhibits73: Data Table on Market opportunity by Application ($ million)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on APAC - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on APAC - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on South America - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on South America - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on South America - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on South America - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits112: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits113: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits116: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits117: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits119: Market opportunity By Geographical Landscape ($ million)
Exhibits120: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits121: Impact of drivers and challenges in 2022 and 2027
Exhibits122: Overview on Criticality of inputs and Factors of differentiation
Exhibits123: Overview on factors of disruption
Exhibits124: Impact of key risks on business
Exhibits125: Vendors covered
Exhibits126: Matrix on vendor position and classification
Exhibits127: Bayer AG - Overview
Exhibits128: Bayer AG - Business segments
Exhibits129: Bayer AG - Key news
Exhibits130: Bayer AG - Key offerings
Exhibits131: Bayer AG - Segment focus
Exhibits132: Beijing Beilu Pharmaceutical Co. Ltd. - Overview
Exhibits133: Beijing Beilu Pharmaceutical Co. Ltd. - Product / Service
Exhibits134: Beijing Beilu Pharmaceutical Co. Ltd. - Key offerings
Exhibits135: Bracco Spa - Overview
Exhibits136: Bracco Spa - Product / Service
Exhibits137: Bracco Spa - Key offerings
Exhibits138: Covis Pharma GmbH - Overview
Exhibits139: Covis Pharma GmbH - Product / Service
Exhibits140: Covis Pharma GmbH - Key offerings
Exhibits141: GE Healthcare Technologies Inc. - Overview
Exhibits142: GE Healthcare Technologies Inc. - Business segments
Exhibits143: GE Healthcare Technologies Inc. - Key offerings
Exhibits144: GE Healthcare Technologies Inc. - Segment focus
Exhibits145: Guerbet - Overview
Exhibits146: Guerbet - Product / Service
Exhibits147: Guerbet - Key offerings
Exhibits148: iMAX Diagnostic Imaging Ltd. - Overview
Exhibits149: iMAX Diagnostic Imaging Ltd. - Product / Service
Exhibits150: iMAX Diagnostic Imaging Ltd. - Key offerings
Exhibits151: Interpharma Praha as - Overview
Exhibits152: Interpharma Praha as - Product / Service
Exhibits153: Interpharma Praha as - Key offerings
Exhibits154: Jodas Expoim Pvt. Ltd. - Overview
Exhibits155: Jodas Expoim Pvt. Ltd. - Product / Service
Exhibits156: Jodas Expoim Pvt. Ltd. - Key offerings
Exhibits157: Lantheus Holdings Inc. - Overview
Exhibits158: Lantheus Holdings Inc. - Business segments
Exhibits159: Lantheus Holdings Inc. - Key offerings
Exhibits160: Lantheus Holdings Inc. - Segment focus
Exhibits161: Livealth Biopharma Pvt. Ltd. - Overview
Exhibits162: Livealth Biopharma Pvt. Ltd. - Product / Service
Exhibits163: Livealth Biopharma Pvt. Ltd. - Key offerings
Exhibits164: M.Biotech Ltd. - Overview
Exhibits165: M.Biotech Ltd. - Product / Service
Exhibits166: M.Biotech Ltd. - Key offerings
Exhibits167: Nano Therapeutics Pvt. Ltd. - Overview
Exhibits168: Nano Therapeutics Pvt. Ltd. - Product / Service
Exhibits169: Nano Therapeutics Pvt. Ltd. - Key offerings
Exhibits170: Spago Nanomedical AB - Overview
Exhibits171: Spago Nanomedical AB - Product / Service
Exhibits172: Spago Nanomedical AB - Key offerings
Exhibits173: Taejoon Pharm Co. Ltd. - Overview
Exhibits174: Taejoon Pharm Co. Ltd. - Product / Service
Exhibits175: Taejoon Pharm Co. Ltd. - Key offerings
Exhibits176: Inclusions checklist
Exhibits177: Exclusions checklist
Exhibits178: Currency conversion rates for US$
Exhibits179: Research methodology
Exhibits180: Validation techniques employed for market sizing
Exhibits181: Information sources
Exhibits182: List of abbreviations